| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 04/19/2006 | EP1339695B1 Farnesyltransferase inhibitors |
| 04/19/2006 | EP1299102B1 Use of riluzole or its salts for preventing and treating adrenoleukodystrophy |
| 04/19/2006 | EP1204650B1 Substituted 2-arylbenzazole compounds and their use as antitumour agents |
| 04/19/2006 | EP1189890B1 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 04/19/2006 | EP1177176B1 Tri-aryl acid derivatives as ppar receptor ligands |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | CN1761673A Guanidine derivatives and use thereof as neuropeptide FF receptor antagonists |
| 04/19/2006 | CN1761656A 3-(1-[3-(1,3-benzothiazol-6-yl)propylcarbamoyl]cycloalkyl)propanoic acid derivatives as NEP inhibitors |
| 04/19/2006 | CN1761655A Thiazole derivatives and their use as VAP-1 inhibitors |
| 04/19/2006 | CN1760190A Method for preparing trifluoromethyl benzothiazole |
| 04/19/2006 | CN1760189A Method for preparing N-alkoxy carbonyl, thiazolethioketone derivative,s and usage |
| 04/19/2006 | CN1760188A N-acyl-2 oxo-1,3-derivatives of thiazolidine, preparation method and usage |
| 04/19/2006 | CN1252067C Benzazole derivatives and their use as JNK modulators |
| 04/19/2006 | CN1252057C Thiazole derivatives for treating PPAR related disorders |
| 04/19/2006 | CN1252055C Biphenyl carboxamides compounds |
| 04/19/2006 | CN1252047C Benzene sulfonic derivative |
| 04/18/2006 | US7030143 Heterocyclic compounds |
| 04/18/2006 | US7030135 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |
| 04/18/2006 | US7030116 Compounds and compositions as cathepsin inhibitors |
| 04/18/2006 | CA2360943C N2-phenylamidine derivatives |
| 04/13/2006 | WO2006038871A1 New hydroxymethylbenzothiazoles amides |
| 04/13/2006 | WO2006038550A1 Medicinal composition for prevention or treatment of parasitic protozoan infection |
| 04/13/2006 | WO2006038513A1 Anti-trypanosomiasis agent |
| 04/13/2006 | WO2006038039A1 Modulators of hcv replication |
| 04/13/2006 | WO2006037950A1 Method of deprotection |
| 04/13/2006 | US20060079691 Ionic liquids having [n(cf3)2]-anions |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079530 Farnesyl transferase inhibitors |
| 04/13/2006 | US20060079528 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors |
| 04/13/2006 | US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/13/2006 | US20060079503 Thiazolidinones and the use therof as polo-like kinase inhibitors |
| 04/13/2006 | DE102004048877A1 New tricyclic thiazole derivatives useful as PI3 kinase inhibitors, for treating e.g. inflammatory and allergic airway and skin diseases, autoimmune and kidney disease |
| 04/13/2006 | DE102004023635A1 Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate Heteroaryl-cyclohexyl-1,4-diamine derivatives |
| 04/13/2006 | CA2582760A1 Modulators of hcv replication |
| 04/12/2006 | EP1645552A1 Double-spiro organic compounds and electroluminescent devices |
| 04/12/2006 | EP1644345A1 Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors |
| 04/12/2006 | EP1644321A2 New benzamides as ppaty modulators |
| 04/12/2006 | EP1644320A1 Indane derivates as muscarinic receptor agonists |
| 04/12/2006 | EP1644314A1 Method for producing difluoro-acetyl-acetic acid alkylesters |
| 04/12/2006 | EP1643993A2 Substituted isochroman compounds for the treatment of metabolic disorders, cancer and other diseases |
| 04/12/2006 | EP1495015B1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers |
| 04/12/2006 | EP1389192B1 Ether carboxylic acids based on alkoxylated mercaptobenzothiazole and the use of the same as corrosion inhibitors |
| 04/12/2006 | EP1349854B1 Hetaryl substituted homotetramic and homotetronic acids and the use thereof as pesticides |
| 04/12/2006 | EP1311499B1 Bicyclic compounds as h3 receptor ligands |
| 04/12/2006 | CN1759115A Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 04/12/2006 | CN1759105A Insecticidal phthalamide derivatives |
| 04/12/2006 | CN1758907A Amino acid phenoxy ethers |
| 04/12/2006 | CN1250735C Method for production of non-proteinogen L-amino acid by fermentation |
| 04/12/2006 | CN1250574C Free-radical polymerised compound |
| 04/12/2006 | CN1250533C Novel azoles having an insecticidal action |
| 04/11/2006 | US7026342 treating fibrotic lung diseases and fibrotic hypertrophy or fibrosis of prostate, liver, the pleura, pancreas or bowel wall with saturated and unsaturated azoles and salts, e.g., 3-[2-phenyl-2-oxoethyl]-4,5-dimethyl-thiazolium salt |
| 04/11/2006 | US7026341 Hetaryl substituted homotetramic and homotetronic acids and their use thereof as pesticides |
| 04/11/2006 | US7026339 Inhibitors of HCV NS5B polymerase |
| 04/11/2006 | US7026334 Thiazolidine compounds and pharmaceutical compositions exhibiting thrombopoietin receptor agonism |
| 04/11/2006 | US7026321 piperazine derivatives, e.g., (2R)-1-(2-methylbenzothiazol-5-yloxy)-3-[4-({5-[4-(trifluoromethyl)phenyl](4,5-dihydroisoxazol-3-yl)}methyl)piperazinyl]propan-2-ol; treating diabetes, arrhythmia, intermittent claudication, angina, congestive heart disease, and myocardial infarction |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/11/2006 | US7026307 Decyclization of a 1-heterocyclylmethyl-2-nitroimino-1,3,5-hexahydrotriazine compound with hydrogen halide in presence of a nitrile to form a 1-heterocyclylmethyl-2-nitroguanidine compound |
| 04/11/2006 | CA2181570C Metalloproteinase inhibitors |
| 04/11/2006 | CA2178632C Pharmaceutical compositions containing hiv protease inhibitors |
| 04/06/2006 | WO2006035685A1 Intermediate of 6-substituted-1-methyl-1-h-benzimidazole derivative and method for producing same |
| 04/06/2006 | WO2005100331A3 Antidiabetic agents |
| 04/06/2006 | WO2005049532A3 A process for purification |
| 04/06/2006 | WO2005007798A3 Hydroxypropyl methacrylamide polymers and copolymers comprising reactive thiazoline-2-thione |
| 04/06/2006 | US20060074247 Improving storage stability by reacting with hydrogen sulfate lithium- containing compound; aspartyl protease inhibitors |
| 04/06/2006 | US20060074110 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/05/2006 | EP1642590A1 Pain threshold fall inhibitor |
| 04/05/2006 | EP1641789A2 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 04/05/2006 | EP1641765A1 Aryl-heteroaromatic products, compositions containing same and use thereof |
| 04/05/2006 | EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 04/05/2006 | EP1641453A2 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 04/05/2006 | EP1641452A1 Heterocyclic compounds useful to treat hcv |
| 04/05/2006 | EP1300398B1 Propane-1,3-dione derivatives |
| 04/05/2006 | EP1173427B1 Hydroxamic acid derivative |
| 04/05/2006 | EP1140846B1 Aspartic protease inhibitors |
| 04/05/2006 | CN1249056C Inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1249053C Nitrate salt of anti-ulcer medicine |
| 04/05/2006 | CN1249040C High dissolvability azo metal chelate and synthesis method thereof |
| 04/05/2006 | CN1249039C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I |
| 04/05/2006 | CN1249024C Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof |
| 04/05/2006 | CN1248683C Treatment of type 2 diabetes mellitus using inhibitors of dipeptidyl peptidase IV |
| 04/04/2006 | US7022825 Polyketides and antibiotics |
| 04/04/2006 | US7022823 A benzothiazole ring containing compound with at least one diazonium salt |
| 04/04/2006 | US7022723 Heterocyclic compounds |
| 04/04/2006 | US7022722 5-(ester-substituted benzyl or benzylidene)-thiazolidine-2,4-diones; readily metabolized by the physiological metabolic drug detoxification systems without loss of therapeutic benefit; lower side effects and toxicity in patients with elevated or compromised liver function |
| 04/04/2006 | US7022721 3-carboxymethyl-thiazolium derivatives, 2 substituted by alkyl, 1-hydroxyalkyl, or 1-benzoyloxyalkyl; uncoupling sugar-mediated coupling of proteins, lipids, nucleic acids, resulting from reaction with glucose and other reducing sugars; changing deformability, increase the tissue diffusion coefficient |
| 04/04/2006 | US7022719 Comprises 3-(2-phenyl-2-oxoethyl)-4,5-dimethylthiazolium chloride; for inhibiting protein aging/non-enzymatic crosslinking; immunoassays; for treatment of cataracts |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022704 5,6,7, 8-tetrahydro-imidazo-(1,2a)-pyrazine derivative; useful for treating restenosis and tumor |
| 04/04/2006 | CA2294624C Cationic monobenzene nitrophenylenediamines, their use in dying keratin fibres, dyeing compositions containing them and dyeing processes |
| 04/04/2006 | CA2179284C Substituted unsymmetrical cyanine dyes with selected permeability |
| 03/30/2006 | WO2006034277A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
| 03/30/2006 | WO2006016724A3 Liquid-crystalline compounds, compositions and thin films |
| 03/30/2006 | WO2006008545A3 Thiazole and isothiazole derivatives as protein kinase inhibitors |
| 03/30/2006 | US20060069282 Process for producing aromatic nitrile compound |
| 03/30/2006 | US20060069265 Reacting cysteine (or a salt or an ester) and an aryl carboxylic acid to form a thiazoline ring; stereospecifically alkylating the thiazoline ring, and hydrolyzing the thiazoline ring to obtain a 2-alkylcysteine; chelation |
| 03/30/2006 | US20060069264 Aza hydroxylated ethyl amine compounds |
| 03/30/2006 | US20060069263 Process for the reduction of (S)-2-amino-6-propionamido-4,5,6,7-tetrahydrobenzo-thiazole |
| 03/30/2006 | US20060069138 Thiazole-based nitric oxide donors having alkyl substuent(s) and uses thereof |
| 03/30/2006 | US20060069137 Novel process for ezetimibe intermediate |
| 03/30/2006 | US20060069134 Process for producing optically active alpha-substituted cysteine or salt thereof, intermediate therefor, and process for producing the same |